Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors

Clinical trial NCT03387020 · COMPLETED

Trial details

NCT number: NCT03387020
Sponsor: Pediatric Brain Tumor Consortium
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

CNS Embryonal Tumor, Not Otherwise Specified Malignant Glioma Recurrent Atypical Teratoid/Rhabdoid Tumor Recurrent Childhood Ependymoma Recurrent Diffuse Intrinsic Pontine Glioma Recurrent Medulloblastoma Refractory Diffuse Intrinsic Pontine Glioma

Start date: 2018-01-13
Primary completion: 2020-04-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.